HeberFERON is an innovative combination therapy developed in Cuba, designed for the treatment of basal cell carcinoma (BCC) and other types of skin cancer. This novel therapeutic approach combines two types of interferons—alpha-2b and gamma—providing a unique mechanism of action that enhances the immune response against cancer cells. This document delves into the scientific basis,...
AllCardiovascularChild DevelopmentCuba’s AchievementsCubaHeal NewsDermatologyEducationEndocrinologyGeriatricGynecologyInternational CollaborationMedical (General)NeurologyOncologyOphthalmologyOrthopedicPsychiatrySubstance Abuse RehabilitationTravel InsuranceUncategorized
CubaHeal Research At the National Extension Workshop conference carried on September 27th, 2017 in the province of Camagüey, doctors from the provinces of Cienfuegos and Sancti Spíritus presented their evidence and application results on the effectiveness of the use of Heberferon for the treatment of Gorlin Syndrome. Gorlin Syndrome, also known as Nevoid Basal-Cell Carcinoma...